Families of Spinal Muscular Atrophy Announces Repligen Corporation Receives ... Families of Spinal Muscular Atrophy Families of Spinal Muscular Atrophy announced today that Repligen Corporation has received approval from the US Food and Drug Administration to commence a Phase I safety study in healthy volunteers for RG3039, formerly called Quinazoline495, ... |
No comments:
Post a Comment